Oncolytics Biotech Inc. appointed Matt Coffey as president and CEO, effective immediately.
Coffey was named the company's interim president and CEO in November 2016.
Oncolytics Biotech's interim CEO to head company on a permanent basis
Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds
Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall
Global M&A By the Numbers: Q1 2022
Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes
Oncolytics Biotech Inc. appointed Matt Coffey as president and CEO, effective immediately.
Coffey was named the company's interim president and CEO in November 2016.